chemotherapy for breast cancer side effects
Tài liệu Screening for Breast Cancer: Systematic Evidence Review Update for the U. S. Preventive Services Task Force doc
Ngày tải lên :
14/02/2014, 21:20
... individual
risks for breast cancer 60-85% and may be identified in 5-10% of all breast cancer cases.
28
Personal history of noninvasive breast cancer or previous abnormal breast biopsy containing ... participants for women age 40-49 years that
reported relative risk (RR) reduction in breast cancer mortality. We conducted similar updates
for other age groups for context. We used breast cancer ... risk for breast cancer mortality of 0.83 (95% confidence
interval [CI], 0.66-1.04) for women randomly assigned to screening, and a number needed to
invite for screening to prevent one breast cancer...
- 95
- 1K
- 0
Tài liệu SCREENING FOR BREAST CANCER WITH MAMMOGRAPHY ppt
Ngày tải lên :
15/02/2014, 05:20
... background for our information in this
leaflet below.
SCREENING FOR BREAST CANCER
WITH MAMMOGRAPHY
What are the benefits and harms of attending a
screening programme for breast cancer? ... treatment for breast cancer in Norway: comparative
analysis of cancer registry data. BMJ 2011;343:d4692.
20. NHS cancer screening programmes. BASO Breast Audit 1999/2000.
www.cancerscreening.nhs.uk/breastscreen/publications.html ... disease and cancer.
It therefore no longer seems reasonable to attend for breast
cancer screening. In fact, by avoiding going to screening, a woman
will lower her risk of getting a breast cancer...
- 15
- 528
- 3
Báo cáo sinh học: " Encapsulation of docetaxel in oily core polyester nanocapsule intended for breast cancer therapy" pptx
Ngày tải lên :
18/06/2014, 22:20
... nanocapsule form. This observation
was consistent with a previous report [48] related to a nanoparticulate form of another
anticancer drug (doxorubicin) tested on a different breast cancer cell ... characterized for particle size,
zeta potential, EE%, drug release kinetics, morphology, crystallinity, and cytotoxicity on the
SUM 225 breast cancer cell line by dynamic light scattering, high performance ... acceptance. Fully formatted
PDF and full text (HTML) versions will be made available soon.
Encapsulation of docetaxel in oily core polyester nanocapsule intended for
breast cancer therapy
Nanoscale...
- 24
- 474
- 0
Báo cáo hóa học: " A Novel Docetaxel-Loaded Poly (e-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment" pot
Ngày tải lên :
22/06/2014, 00:20
... in
human breast cancer cells and therefore have considerable
potential for treatment of breast cancer.
Keywords Nanoparticles Á MDR Á Pluronic F68 Á
Poly (e-caprolactone) Á Docetaxel Á Breast cancer
Introduction
Cancer ... multidrug resistance in
human breast cancer cells and therefore have considerable
potential for treatment of breast cancer.
Acknowledgments The authors are grateful for financial support
from the ... 54.37% for Taxotere
Ò
to 49.16% (i.e. a
11.42% increase in cytotoxicity, p [ 0.05) for PCL NP
formulation and 36.63% (i.e. a 38.88% increase in cyto-
toxicity, p \0.05) for PCL/Pluronic F68 NP formulation.
Similarly,...
- 10
- 363
- 0
Báo cáo sinh học: "Reasons for breast cancer heterogeneity" pptx
Ngày tải lên :
06/08/2014, 18:21
... treatment is therefore not as effective as it
should be. Mortality due to breast cancer is decreasing in
most western countries, because of mass screening, frequent
use of post-operative chemotherapy ... understood breast cancer heterogeneity
better. Two recent papers in Genome Biology from the
laboratories of Carlos Caldas [1] and Eric Miska [2] use
molecular methods to classify breast cancers ... hheetteerrooggeenneeiittyy
Because breast cancer heterogeneity arises from many
different factors, several directions of research must be
pursued simultaneously if we are to understand and cope
with the different forms of breast...
- 4
- 422
- 0
báo cáo khoa học: "Axillary lymph node dissection for breast cancer utilizing Harmonic Focus®" pps
Ngày tải lên :
09/08/2014, 02:20
... CS, Nelson BK: Seroma formation
following breast cancer surgery. Breast J 2003, 5:385-8.
10. Woodworth PA, McBoyle MF, Helmer SD, Beamer RL: Seroma formation
after breast cancer surgery: incidence ... of
seromas following breast cancer surgeries: seromas following breast
cancer surgeries. Breast J 2007, 13:588-92.
21. Burak WE Jr, Goodman PS, Young DC, Farrar WB: Seroma formation
following ... suction
drainage for the axillary wound after lymphadenectomy for breast
cancer. Br J Surg 2006, 93:820-4.
32. Gong Y, Xu J, Shao J, Cheng H, Wu X, Zhao D, Xiong B: Prevention of
seroma formation after...
- 5
- 349
- 0
báo cáo khoa học: "Clinical relevance of "withdrawal therapy" as a form of hormonal manipulation for breast cancer" doc
Ngày tải lên :
09/08/2014, 02:21
... localized
estrogen receptors in human breast cancer. Cancer Res 1990,
5012:3545-3550.
9. British Breast Group: Assessment of response to treatment in advanced
breast cancer. Lancet 1974, 2:38-39.
10. ... receptor positive, operable
primary breast cancer in elderly (age > 70 years), locally advanced or metastatic breast cancer; (2) disease deemed
suitable for treatment by hormonal manipulation; ... therapy.
Methods
Case-notes of the breast cancer patients treated in the
Nottingham breast unit since 1998 fulfilling the follow-
ing criteria were studied retrospectively:
• ER positive invasive breast carcinoma...
- 4
- 253
- 0
báo cáo khoa học: "Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer" pdf
Ngày tải lên :
09/08/2014, 02:21
... (preoperative and postoperative) chemotherapy
for locally advanced gastric cancer [3]. Up to this point, many neoadjuvant
chemotherapy treatments for gastric cancer have been used with varying ... relaparotomies after 700 gastretomies
performed for gastric cancer. Am J Surg 1996; 171(2): 270-3.
10. Sasako M. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial.
Br J Surg 1997; ... and regional lymph nodes without leaving any
macroscopically visible cancer lesions. Neoadjuvant chemotherapy for gastric cancer
aims to downstage the tumour, thus improving the curative resectability...
- 27
- 239
- 0
